
According to Benzinga Pro data, during Q4, Evolus (NASDAQ:EOLS) posted sales of $34.66 million. Earnings were up 6.46%, but Evolus still reported an overall loss of $18.18 million. Evolus collected $26.68 million in revenue during Q3, but reported earnings showed a $19.43 million loss.